The benefits of mass spectrometry are now scalable for the first time — and that gives pathology labs a new value proposition
Lab leaders are facing a perfect storm of challenges right now: staff shortages, budget constraints and rising sample volumes1. That creates inefficiencies. It delays critical diagnoses for the patients waiting for answers.
Could mass spectrometry — the gold standard for efficiency, sensitivity and specificity2 — hold the solution? Not long ago, it didn’t. Mass spectrometry was seen as a resource-intensive niche requiring highly specialised staff and complex workflows3.
Now, though, the next generation of mass spectrometry can reshape lab operations — without the manual complexity, specialised silos, or high operational overhead.
Here’s how.
1. It brings testing out of the ‘silo’ and into the core lab
Historically, mass spectrometry was housed in dedicated rooms with specialised equipment, separated from routine workflows4. But modern systems are designed to integrate physically and digitally into the routine lab environment. This operational shift eliminates the inefficiencies of moving samples between sections and creates a more streamlined, unified workflow.
2. It bridges the talent gap through advanced automation
Clinical mass spectrometrists are in high demand and low supply5. Combined with the need for multiple (and often highly fragmented) manual pre-analytical phases in the workflow, this talent shortage creates a major barrier to adoption. New platforms solve this problem. With fully automated, sample-to-result workflows, typical analysis time of two to five minutes6 and 24/7 reliability with continuous, random-access testing, labs can significantly reduce turnaround time without making new hires.
3. It creates a ‘complementary’ workflow for maximum efficiency
By running mass spectrometry alongside standard immunoassays, labs can route routine samples to high-volume analysers while sending complex cases2 to mass spectrometry. This ensures the right technology is used for the right patient, optimising the overall speed and accuracy of the lab.
4. It scales diagnostic capabilities without linear cost increases
Ever higher demand for diagnostics means labs now need to offer more tests, and process more samples, without substantial increases in costs. The new generation of mass spectrometry allows labs to significantly expand their test menus to include new parameters, panel testing, and complex specimen types; this scalability makes routine, high-volume diagnostics with mass spectrometry possible for the first time.
5. It shifts the focus from ‘results’ to ‘holistic patient care’
The pathology lab of the future integrates mass spectrometry data with other diagnostic results and algorithms. It sits side-by-side with clinical chemistry and immunochemistry. That gives clinicians a comprehensive diagnostic profile of a patient’s health — and for the patient themselves, it means faster paths to the right treatment. It means precision medicine. It means they can play a more active, confident role in their own treatment decisions.
The new gold standard for pathology can become routine
Mass spectrometry is no longer a complex, high-resource technology that’s out of reach for the majority of labs. By embracing automation, integration, and standardisation, it’s the tool lab leaders need to scale the most efficient, sensitive, accurate tests — and embed them into routine care pathways.
There’s enormous potential for innovations like mass spectrometry to change millions of lives — but only if lab and health system leaders know about them. To that end, please help us spread the word: like, share or repost this article. Thank you.
